Glenn Sblendorio, CEO at IVERIC bio, Inc. (ISEE), sold 901 shares at $17.01 ($15K) on 2021-12-31, disclosed to the SEC on 2022-01-03.
Scheduled sale ($15k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 100 | $2K | 11.1% |
| 2 | $17.01 | 801 | $14K | 88.9% |
| Total | $17.01 avg | 901 | $15K | 100% |
| Filing → |
| ISEE | SELL | 2022-11-04 | $1.2M | — | Filing → |
| ISEE | SELL | 2022-04-06 | $1.9M | — | Filing → |
| ISEE | SELL | 2022-04-01 | $758K | — | Filing → |